| Not Yet Recruiting | Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Ovarian Cancer | Phase 1 | 2026-06-01 |
| Not Yet Recruiting | Evaluate the Efficacy and Safety of Empagliflozin or Glimepiride Combination Therapy in Type 2 Diabetes Mellit Diabete Type 2 | Phase 4 | 2026-03-01 |
| Not Yet Recruiting | A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancer Advanced Solid Tumors, Non-Small Cell Lung Cancer | Phase 1 / Phase 2 | 2026-03-01 |
| Not Yet Recruiting | A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 Benign Prostate Hypertrophy(BPH) | Phase 1 | 2026-02-23 |
| Recruiting | A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixe Atopic Dermatitis | Phase 1 | 2026-02-09 |
| Recruiting | Pharmacokinetic, Safety, Tolerability, and Immunogenicity Comparison of CKD-704 (Risankizumab Biosimilar), Wit Psoriasis | Phase 1 | 2025-11-26 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.25/12.5/1000mg in Healthy Volunteers Type 2 Diabetes | Phase 1 | 2025-10-30 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/10/1000mg in Healthy Volunteers Type 2 Diabetes | Phase 1 | 2025-10-28 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-383 0.5/25/1000mg in Healthy Volunteers Type 2 Diabetes | Phase 1 | 2025-10-24 |
| Recruiting | Phase Ia/Ib Study of CKD-512 Alone and in Combination With Pembrolizumab in Subjects With Advanced or Metastat Advanced Solid Tumors, Metastatic Solid Tumors | Phase 1 | 2025-10-16 |
| Not Yet Recruiting | Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Pa Heart Transplant | Phase 4 | 2025-08-14 |
| Completed | A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Healthy | Phase 1 | 2025-05-14 |
| Not Yet Recruiting | A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia Androgenetic Alopecia | Phase 3 | 2025-04-30 |
| Completed | Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981 Knee Osteoarthritis | Phase 2 | 2025-04-28 |
| Completed | Clinical Study to Evaluate Drug-drug Interaction and Safety After Co-administration of D352 and D794 in Health Dyslipidemia | Phase 1 | 2024-11-27 |
| Completed | A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participants Healthy Subjects | Phase 1 | 2024-11-14 |
| Completed | Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2024-11-08 |
| Completed | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/25/1000mg in Healthy Volunteers Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2024-11-06 |
| Completed | Clinical Study to Evaluate the Food Effect of CKD-383 0.5/10/1000mg in Healthy Volunteers Type 2 Diabetes Mellitus (T2DM) | Phase 1 | 2024-11-06 |
| Completed | A Clinical Trial to Evaluate the Food Effect of CKD-379 Type II Diabetes Mellitus | Phase 1 | 2024-11-05 |
| Recruiting | Phase 3 Trial to Evaluate the Efficacy and Safety of CKD-202A Essential Hypertension | Phase 3 | 2024-10-14 |
| Not Yet Recruiting | To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers Type 2 Diabetes Mellitus | Phase 1 | 2024-07-04 |
| Completed | A Clinical Trial to Evaluate the Food Effect of CKD-378 Type II Diabetes Mellitus | Phase 1 | 2024-05-03 |
| Completed | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy S Type 2 Diabetes Mellitus | Phase 1 | 2024-04-04 |
| Completed | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and Hypertension | Phase 1 | 2024-03-22 |
| Recruiting | Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes Diabetes Mellitus, Type 2 | — | 2024-03-16 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6) Hypertension, Dyslipidemias | Phase 1 | 2024-01-04 |
| Completed | A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 Type 2 Diabetes Mellitus | Phase 1 | 2023-11-21 |
| Completed | MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients Kidney Transplant | Phase 4 | 2023-11-14 |
| Completed | A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846 Benign Prostate Hypertrophy(BPH) | Phase 1 | 2023-11-13 |
| Completed | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2) Dyslipidemias | Phase 1 | 2023-10-23 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Mo Essential Hypertension | Phase 3 | 2023-07-31 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg Hypertension and Dyslipidemia | Phase 1 | 2023-07-17 |
| Completed | Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150 Type 2 Diabetes | Phase 1 | 2023-07-14 |
| Completed | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150 Diabetes type2 | Phase 1 | 2023-07-10 |
| Completed | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg Hypertension | Phase 1 | 2023-07-04 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Essential Hypertension | Phase 3 | 2023-06-28 |
| Completed | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and Hypertension | Phase 1 | 2023-06-20 |
| Unknown | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 Type II Diabetes Mellitus | Phase 1 | 2023-06-02 |
| Unknown | A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive P Essential Hypertension, Metabolic Syndrome | Phase 4 | 2023-06-01 |
| Completed | Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-admi Type II Diabetes | Phase 1 | 2023-06-01 |
| Completed | Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CK Type 2 Diabetes | Phase 1 | 2023-05-26 |
| Completed | A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 Hypertension | Phase 1 | 2023-05-02 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5) Hypertension and Dyslipidemia | Phase 1 | 2023-04-22 |
| Recruiting | Efficacy and Safety of Telmisartan Compared With Losartan Diabetic Nephropathies, Hypertension | Phase 4 | 2023-04-19 |
| Completed | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378 Type II Diabetes | Phase 1 | 2023-04-11 |
| Completed | Pharmacokinetics and Safety/Tolerability of CKD-379 Type II Diabetes Mellitus | Phase 1 | 2023-02-27 |
| Completed | Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition Endocrine, Nutritional and Metabolic Diseases | Phase 1 | 2023-02-01 |
| Completed | A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391 Dyslipidemias | Phase 1 | 2022-12-20 |
| Completed | A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia Androgenetic Alopecia | Phase 2 | 2022-12-20 |
| Recruiting | Efficacy and Safety of EsoDuo® Gastro Esophageal Reflux | Phase 4 | 2022-11-25 |
| Unknown | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hyperchol Primary Hypercholesterolemia | Phase 3 | 2022-11-24 |
| Completed | The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A Alopecia | Phase 1 | 2022-11-15 |
| Completed | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects Hypertension | Phase 1 | 2022-11-02 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects Type II Diabetes Mellitus | Phase 1 | 2022-10-21 |
| Completed | The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients with Type 2 Diabetes Type 2 Diabetes | Phase 3 | 2022-10-12 |
| Completed | Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348 Hypertension and Dyslipidemia | Phase 1 | 2022-09-29 |
| Unknown | Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy Essential Hypertension | Phase 3 | 2022-09-28 |
| Completed | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fast Hypertension and Dyslipidemia | Phase 1 | 2022-09-23 |
| Completed | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Endocrine, Nutritional and Metabolic Diseases | Phase 1 | 2022-09-19 |
| Completed | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fast Endocrine, Nutritional and Metabolic Diseases | Phase 1 | 2022-09-16 |
| Completed | Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects Hypertension | Phase 1 | 2022-09-15 |
| Completed | A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food o Healthy Volunteers | Phase 1 | 2022-08-24 |
| Completed | Pharmacokinetics and Safety/Tolerability Profile of CKD-379 Type II Diabetes Mellitus | Phase 1 | 2022-07-26 |
| Completed | Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393 Type II Diabetes Mellitus | Phase 1 | 2022-06-21 |
| Completed | Study to Evaluate the Safety and Pharmacokinetics of CKD-331 Hypertension and Dyslipidemia | Phase 1 | 2022-05-31 |
| Completed | A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Cond Type2Diabetes | Phase 1 | 2022-04-21 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg Hypertension and Dyslipidemia | Phase 1 | 2022-03-15 |
| Completed | CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects Drug Drug Interaction | Phase 1 | 2022-02-28 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) Hypertension and Dyslipidemia | Phase 1 | 2022-02-23 |
| Completed | Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and Glaucoma | Phase 1 | 2022-01-19 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects Chronic Hepatitis b | Phase 1 | 2022-01-14 |
| Completed | Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393 Type 2 Diabetes | Phase 1 | 2021-11-25 |
| Active Not Recruiting | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Pati Kidney Transplantation | Phase 4 | 2021-11-19 |
| Completed | Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers Chronic Heart Failure | Phase 1 | 2021-11-03 |
| Unknown | A Study to Evaluate the PK, PD and Safety of CKD-382 in Healthy Subjects GERD | Phase 1 | 2021-10-07 |
| Unknown | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients Wi Mild Cognitive Impairment | Phase 4 | 2021-09-30 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg Hypertension and Dyslipidemia | Phase 1 | 2021-09-12 |
| Unknown | A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment P Vascular Cognitive Impairment | Phase 4 | 2021-09-01 |
| Completed | Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers Chronic Renal Failure | Phase 1 | 2021-07-19 |
| Unknown | Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of CKD-314 COVID-19 Pneumonia | Phase 3 | 2021-06-30 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) Hypertension and Dyslipidemia | Phase 1 | 2021-06-04 |
| Unknown | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Condit Cardiovascular Diseases | Phase 1 | 2021-06-04 |
| Unknown | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions Cardiovascular Diseases | Phase 1 | 2021-06-04 |
| Completed | Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg Type 2 Diabetes Mellitus | Phase 1 | 2021-05-27 |
| Completed | A Clinical Traial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of CKD-843 Alopecia | Phase 1 | 2021-04-30 |
| Unknown | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers Anticoagulant | Phase 1 | 2021-04-27 |
| Completed | A Study to Investigate the Effect of Food on the PK, PD of CKD-381 in Healthy Volunteers GERD | Phase 1 | 2021-04-21 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-383. Type2 Diabetes Mellitus | Phase 1 | 2021-04-16 |
| Unknown | The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 Early Puberty | Phase 1 | 2021-04-01 |
| Completed | A Study to Investigate the PK and Safety of CKD-393 Type II Diabetes | Phase 1 | 2021-03-26 |
| Unknown | Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients Liver Transplant | Phase 4 | 2021-03-16 |
| Unknown | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388 in Healthy Subjects Chronic Hepatitis b | Phase 1 | 2021-02-26 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) Hypertension and Dyslipidemia | Phase 1 | 2021-02-20 |
| Unknown | Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393 T2DM (Type 2 Diabetes Mellitus) | Phase 1 | 2021-02-18 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 Hypertension and Dyslipidemia | Phase 1 | 2021-01-17 |
| Completed | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 Hypertension and Dyslipidemia | Phase 1 | 2021-01-09 |
| Unknown | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. Kidney Transplantation | Phase 4 | 2021-01-01 |
| Completed | A Study Evaluating the Efficacy and Safety of CKD-314 in Hospitalized Adult Patients Diagnosed With COVID-19 P COVID-19 | Phase 2 | 2020-12-21 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetic Profiles and Safety of CKD-845 Hypogonadism | Phase 1 | 2020-11-16 |
| Unknown | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 Anticoagulant | Phase 1 | 2020-11-13 |
| Unknown | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-333 Low Dose in Healthy Volunteers Cardiovascular Disease | Phase 1 | 2020-11-11 |
| Unknown | A Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of CKD-333 or Co-administration of Cardiovascular Diseases | Phase 1 | 2020-11-01 |
| Unknown | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fasting Condit Cardiovascular Diseases | Phase 1 | 2020-10-29 |
| Unknown | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions Cardiovascular Diseases | Phase 1 | 2020-10-27 |
| Completed | A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 Hypertension and Dyslipidemia | Phase 1 | 2020-10-15 |
| Unknown | A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects GERD | Phase 1 | 2020-09-25 |
| Completed | A Study Evaluating the Efficacy and Safety of CKD-314 (Nafabelltan) in Hospitalized Adult Patients Diagnosed W COVID-19 | Phase 2 | 2020-09-25 |
| Completed | Study to Evaluate the Efficacy and Safety of CKD-352 Dry Eye Disease | Phase 3 | 2020-09-22 |
| Unknown | Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics in Healthy Volunteers Cardiovascular Disease | Phase 1 | 2020-07-14 |
| Completed | Evaluation of the Safety and Tolerability of CKD-508 in Healthy Subjects Healthy Subjects | Phase 1 | 2020-07-06 |
| Completed | Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients. Liver Transplant | Phase 4 | 2020-06-30 |
| Completed | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD Type 2 Diabetes Mellitus | Phase 1 | 2020-06-15 |
| Unknown | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | 2020-06-11 |
| Unknown | The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients Non-Small Cell Lung Cancer | Phase 1 | 2020-05-21 |
| Completed | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D745 and D150 Type 2 Diabetes | Phase 1 | 2020-05-07 |
| Completed | Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-393 in Healthy Subjects Diabetes Mellitus, Type 2 | Phase 1 | 2020-04-08 |
| Unknown | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-389 Type 2 Diabetes | Phase 1 | 2020-04-06 |
| Completed | A Clinical Trial to Compare the Pharmacokinetics and Tolerability of CKD-348 Hypertension, Dyslipidemias | Phase 1 | 2020-03-25 |
| Unknown | A Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-396 Type2 Diabetes Mellitus | Phase 1 | 2020-02-24 |
| Completed | Clinical Study to Evauate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers Healthy | Phase 1 | 2020-02-04 |
| Unknown | A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Adult Volun Type2 Diabetes Mellitus | Phase 1 | 2020-02-01 |
| Unknown | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-375 Type2 Diabetes Mellitus | Phase 1 | 2020-01-29 |
| Completed | Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects Healthy Volunteers | Phase 1 | 2020-01-14 |
| Completed | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Gastritis | Phase 3 | 2020-01-06 |
| Completed | Compare the Pharmacokinetics and Safety of CKD-391 Hyperlipidemias | Phase 1 | 2019-10-30 |
| Unknown | Clinical Study to Evaluate the Efficacy and Safety of CKD-348(CKD-828, D326, D337) Tablet Hypertension, Dyslipidemias | Phase 3 | 2019-10-23 |
| Completed | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-385 in Healthy Volunteers Cardiovascular Diseases | Phase 1 | 2019-09-19 |
| Completed | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteer Cardiovascular Diseases | Phase 1 | 2019-09-06 |
| Completed | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Voluntee Cardiovascular Diseases | Phase 1 | 2019-09-06 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-386 Dyslipidemia Patients With Hypertension | Phase 3 | 2019-08-29 |
| Completed | Pharmacokinetics, Safety and Tolerability of CKD-387 10/500mg BE Phase1 Type2 Diabetes Mellitus | Phase 1 | 2019-08-06 |
| Unknown | A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012 Hypertension | Phase 1 | 2019-08-01 |
| Unknown | Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL) Liver Transplant | Phase 4 | 2019-07-31 |
| Completed | Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of CKD-333 in Healthy Volunteers Hypertension, Dyslipidemias | Phase 1 | 2019-07-28 |
| Completed | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers Healthy | Phase 1 | 2019-06-04 |
| Unknown | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation Atrial Fibrillation | Phase 3 | 2019-04-23 |
| Unknown | The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-375 Type 2 Diabetes Mellitus | Phase 1 | 2019-04-14 |
| Unknown | A Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-386 in Healthy Male Volunt Hypertension, Dyslipidemias | Phase 1 | 2019-04-01 |
| Completed | Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers After Meal Benign Prostatic Hyperplasia | Phase 1 | 2019-03-11 |
| Completed | Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. "Harnal-D" in Healthy Volunteers Benign Prostatic Hyperplasia | Phase 1 | 2019-03-11 |
| Completed | Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-374 5 mg in Healthy Volunteers Rheumatoid Arthritis | Phase 1 | 2019-02-26 |
| Unknown | Compare the Pharmacokinetics and Safety of CKD-333 With Co-administration CKD-330 and D090 in Healthy Male Adu Hypertension, Dyslipidemias | Phase 1 | 2019-02-25 |
| Completed | Study to Evaluate the Bioequivalence of Pfizer Korea Inc. "XELJANZ 5Mg Tablet" in Healthy Volunteers Rheumatoid Arthritis | Phase 1 | 2019-02-22 |
| Unknown | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-370 and D745 in Healthy Adults Type 2 Diabetes Mellitus | Phase 1 | 2019-02-19 |
| Completed | A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355 Alzheimer's Disease (AD) | Phase 1 | 2019-02-15 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg Non-erosive Reflux Disease(NERD) | Phase 4 | 2019-01-29 |
| Unknown | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition Type 2 Diabetes Mellitus | Phase 1 | 2019-01-28 |
| Unknown | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults Type2 Diabetes Mellitus | Phase 1 | 2019-01-14 |
| Completed | The Clinical Trial to Investigate the Pharmacokinetics and Safety/Tolerability of CKD-387 Under Fed Condition Type 2 Diabetes Mellitus | Phase 1 | 2019-01-08 |
| Completed | Retrospective Study to Evaluate the Safety of Duvie in Korean Patients With Type 2 Diabetes Mellitus Type2 Diabetes | — | 2019-01-02 |
| Unknown | Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM) Kidney Transplant | Phase 4 | 2018-12-17 |
| Unknown | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 Primary Open-angle Glaucoma, Ocular Hypertension | Phase 3 | 2018-12-07 |
| Completed | A Study Evaluating the Efficacy and Safety of CKD-506 in Adult Subjects With Moderate-to-Severe Rheumatoid Art Rheumatoid Arthritis | Phase 2 | 2018-11-30 |
| Unknown | Clinical Trial to Evaluate Pharmacokinetic Profiles and Safety Between CKD-385 and D935 in Healthy Volunteers Hypertension | Phase 1 | 2018-10-24 |
| Completed | A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration Neovascular(Wet) Age Related Macular Degeneration | Phase 3 | 2018-10-19 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of TenofoBell® Tablet in Chronic Hepatitis B Patients Chronic Hepatitis B | Phase 4 | 2018-09-20 |
| Completed | Compare the Pharmacokinetics and Safety of CKD-391 With Co-administration of D086 and D337 Hyperlipidemias | Phase 1 | 2018-09-05 |
| Completed | Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients Kidney Transplant | Phase 4 | 2018-09-05 |
| Unknown | A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects Dyslipidemias, Hypertension | Phase 1 | 2018-08-31 |
| Unknown | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D484 in Healthy Adults Type II Diabetes | Phase 1 | 2018-08-30 |
| Completed | A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects Dyslipidemias, Hypertension | Phase 1 | 2018-08-09 |
| Completed | Pharmacokinetics and Safety Profile of CKD-333 Hypertension, Dyslipidemias | Phase 1 | 2018-08-08 |
| Completed | Clinical Trial to Evaluate the Drug Drug Interaction of CKD-501 and D308 Diabetes Mellitus, Type II | Phase 1 | 2018-07-25 |
| Unknown | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg Type II Diabetes Mellitus | Phase 1 | 2018-07-16 |
| Completed | A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects GERD | Phase 1 | 2018-06-27 |
| Completed | The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 Respiratory Infection | Phase 2 | 2018-05-29 |
| Completed | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-357 and D578 in Healthy V Acute Coronary Syndrome | Phase 1 | 2018-05-25 |
| Unknown | CKD-504 in SAD and MAD in Healthy Korean and Caucasian Adult Male and Female Subjects Huntington Disease | Phase 1 | 2018-05-23 |
| Unknown | The Efficacy and Safety of CKD-501 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes Type2 Diabetes | Phase 3 | 2018-05-02 |
| Unknown | Efficacy and Safety of CKD-501 Added to D150 Plus D745 25mg Therapy in Patients With Type 2 Diabetes Type2 Diabetes | Phase 3 | 2018-04-26 |
| Completed | CKD-355 Drug-drug Interaction Study (CKD-355 DDI P1) Central Nervous System Diseases | Phase 1 | 2018-04-16 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet Hypertensive Patients With Dyslipidemia | Phase 3 | 2018-04-04 |
| Completed | Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft O Kidney Transplant | Phase 4 | 2018-03-31 |
| Completed | A Study to Compare PK and Safety of CKD-381 and D026 in Healthy Male Subjects GERD | Phase 1 | 2018-03-02 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-495 Tablet Gastritis | Phase 2 | 2018-01-16 |
| Completed | Retrospective Observational Study on GERD Management in General Hospitals in Korea Gastroesophageal Reflux Disease (GERD) | — | 2018-01-03 |
| Completed | Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients. Kidney Transplant | Phase 4 | 2017-11-30 |
| Completed | Efficacy and Safety of CKD-501 Added to D150 Plus D745 10mg Therapy in Patients With Type 2 Diabetes Type2 Diabetes | Phase 3 | 2017-11-07 |
| Completed | A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 Dyslipidemias | Phase 1 | 2017-10-12 |
| Completed | Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg Hypercholesterolemia | Phase 4 | 2017-10-11 |
| Completed | A Clinical Trial to Evaluate the Blood Pressure Lowering Effect of a Candemore Plus Tab Versus Cantabell Tab i Hypertension | Phase 4 | 2017-09-20 |
| Completed | A Study to Compare PK, PD and Safety of CKD-381 in Healthy Subjects GERD | Phase 1 | 2017-06-20 |
| Completed | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 Dyslipidemias | Phase 1 | 2017-05-19 |
| Unknown | CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma Myeloma, Multiple | Phase 1 | 2017-05-10 |
| Completed | Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects Dyslipidemias | Phase 1 | 2017-05-08 |
| Unknown | Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily Glaucoma, Primary Open Angle, Ocular Hypertension | Phase 2 | 2017-03-30 |
| Completed | To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors Dyslipidemias | Phase 2 | 2017-03-23 |
| Completed | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 Dyslipidemia | Phase 1 | 2017-03-07 |
| Completed | The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930 Healthy | Phase 1 | 2017-02-17 |
| Unknown | CKD-581 + Bortezomib + Dexamethasone in Patients With Previously Treated Multiple Myeloma Myeloma, Multiple | Phase 1 | 2017-01-01 |
| Completed | The Study to Evaluate Efficacy and Safety of Celecoxib Capsule in Hand Osteoarthritis Patients Osteoarthritis Hand | Phase 4 | 2016-12-27 |
| Completed | Pharmacokinetic Drug-drug Interaction of CKD-330 and D086 Hypertension, Hyperlipidemias | Phase 1 | 2016-12-01 |
| Unknown | A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. Colorectal Cancer | Phase 1 / Phase 2 | 2016-12-01 |
| Completed | Study to Investigate the Effects of Food on the Pharmacokinetics/Pharmacodynamics of CKD-519 Healthy Volunteers | Phase 1 | 2016-08-01 |
| Unknown | Evaluate the Drug-drugs Interaction Between Lobeglitazone and Empagliflozin Diabetes Mellitus, Type II | Phase 1 | 2016-08-01 |
| Completed | Study to Investigate the Influence of CKD-519 on 24-h Ambulatory Blood Pressure in Healthy Adult Volunteers Healthy Volunteers | Phase 1 | 2016-08-01 |
| Unknown | Study to Evaluate the Efficacy and Safety of CKD-350 Dry Eye Syndrome | Phase 3 | 2016-05-01 |
| Unknown | Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet Chronic Hepatitis B | Phase 3 | 2016-04-01 |
| Completed | CKD-841 Pharmacokinetic/Pharmacodynamic Study Postmenopausal Disorder | Phase 1 | 2016-04-01 |
| Completed | CKD-396 Drug-drug Interaction Study(A) (CKD-396 DDI(A) P1) Diabetes Mellitus, Type II | Phase 1 | 2016-04-01 |
| Completed | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 Dyslipidemia | Phase 1 | 2016-04-01 |
| Completed | CKD-396 Drug-drug Interaction Study(B) (CKD-396 DDI(B) P1) Diabetes Mellitus Type 2 | Phase 1 | 2016-04-01 |
| Completed | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male Voluntee Diabetes Mellitus, Type II | Phase 1 | 2016-02-01 |
| Completed | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 Dyslipidemia | Phase 1 | 2016-01-01 |
| Completed | CKD-330 Phase 3 Trial in Amlodipine Non-responder Hypertension | Phase 3 | 2016-01-01 |
| Completed | A Clinical Trial to Evaluate the Effects of Food on the Bioavailability of CKD-397 in Healthy Male Subjects Benign Prostatic Hypertrophy (BPH) | Phase 1 | 2015-12-01 |
| Unknown | Observational Study to Evaluate the Safety of DILATREND SR Cap. in Korean Patients With Essential Hypertension Essential Hypertension, Chronic Stable Angina, Congestive Heart Failure | — | 2015-11-01 |
| Completed | Study to Compare the Safety and Pharmacokinetics of CKD-397 Benign Prostatic Hyperplasia | Phase 1 | 2015-11-01 |
| Completed | Study to Compare the Safety and Pharmacokinetics of CKD-390 Tablet With Viread® Tablet Chronic Hepatitis B | Phase 1 | 2015-10-01 |
| Completed | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. Dyslipidemia | Phase 1 | 2015-10-01 |
| Completed | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers Diabetes Mellitus, Type II | Phase 1 | 2015-10-01 |
| Unknown | Active Drug Comparative Trial to Evaluate the Antiviral Activity and Safety in Chronic Hepatitis B Patients Hepatitis B, Chronic | Phase 4 | 2015-10-01 |
| Completed | Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazol Aspergillus Infections, Candida Infections, Fungal Infections | Phase 1 | 2015-09-01 |
| Completed | Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients Benign Prostatic Hyperplasia | Phase 3 | 2015-09-01 |
| Completed | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/750 mg in Healthy Male Volunte Diabetes Mellitus, Type II | Phase 1 | 2015-08-01 |
| Completed | Study to Compare the Safety and Pharmacokinetics of CKD-330 8/5mg With Coadministration of the Two Separate Dr Hypertension | Phase 1 | 2015-08-01 |
| Completed | CKD-391 Pharmacokinetic Study Phase I Healthy | Phase 1 | 2015-08-01 |
| Completed | A Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.5/1000 mg in Healthy Male Volunte Diabetes Mellitus, Type II | Phase 1 | 2015-07-01 |
| Completed | CKD-391 Pharmacokinetic Study Healthy | Phase 1 | 2015-07-01 |
| Completed | Study to Investigate the Effect of Food on the Pharmacokinetics/Pharmacodynamics and Safety of CKD-519(CKD-519 Dyslipidemia | Phase 1 | 2015-06-01 |
| Completed | CKD-11101 Phase 3 IV Study in Patients Who Had Renal Anemia Receiving Hemodialysis Anemia of Chronic Kidney Disease | Phase 3 | 2015-06-01 |
| Completed | CKD-11101 Phase 3 SC Study Anemia of Chronic Kidney Disease | Phase 3 | 2015-05-01 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-342 Rhinitis, Allergic, Perennial | Phase 3 | 2015-05-01 |
| Completed | Trial to Evaluate the Efficacy and Safety of a Combination Therapy of Candesartan and Amlodipine Versus Candes Hypertension | Phase 3 | 2015-04-22 |
| Completed | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - B Hypertension | Phase 1 | 2015-04-01 |
| Completed | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A Hypertension | Phase 1 | 2015-04-01 |
| Unknown | Efficacy of a Telmisartan/S-Amlodipine on 24-hour BP Control in Hypertensive Patients Inadequately Controlled Hypertension | Phase 4 | 2015-04-01 |
| Completed | CKD-337(2) Drug-drug Interaction Study Healthy | Phase 1 | 2015-03-17 |
| Completed | Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 Hyperlipidemia | Phase 3 | 2015-03-01 |
| Completed | CKD-828 (80/5mg) Pharmacokinetic Study Hypertension | Phase 1 | 2015-02-01 |
| Completed | Tacrobell tab_Phase1_PK Immunosuppressant(Organ Transplantation, RA) | Phase 1 | 2015-01-12 |
| Unknown | Efficacy and Safety of Lobeglitazone Versus Sitagliptin Diabetes Mellitus, Type 2 | Phase 4 | 2015-01-01 |
| Completed | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers Healthy | Phase 1 | 2014-11-01 |
| Completed | CKD-397 Drug-drug Interaction Study (B) Healty Male Volunteers | Phase 1 | 2014-09-01 |
| Completed | CKD-828 (80/5mg) Pharmacokinetic Study Hypertension | Phase 1 | 2014-09-01 |
| Completed | CKD-397 Drug-drug Interaction Study (A) Healthy | Phase 1 | 2014-09-01 |
| Completed | Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients Acute Gastritis, Chronic Gastritis | Phase 4 | 2014-08-01 |
| Completed | Bioequivalence Study (Candesartan 8 mg and Amlodipine 5 mg) Hypertension | Phase 1 | 2014-07-01 |
| Completed | CKD-330 Drug-Drug Interaction Study (Candesartan) Hypertension | Phase 1 | 2014-06-01 |
| Completed | The Efficacy of a Combination of Telmisartan/S-Amlodipine Compared With Telmisartan Monotherapy Hypertension | Phase 4 | 2014-06-01 |
| Completed | Study to Investigate the Safety/Tolerability and Pharmacokinetics/Pharmacodynamics of CKD-519 Dyslipidemia | Phase 1 | 2014-06-01 |
| Completed | CKD-330 Drug-Drug Interaction Study (Amlodipine) Hypertension | Phase 1 | 2014-05-01 |
| Completed | Comparative Evaluation of Pharmacokinetics After CKD-501 Between Renal Impaired and Normal Renal Function Subj Renal Impairment, Healthy | Phase 1 | 2014-04-01 |
| Completed | CKD-337 Drug Interaction Study Dyslipidemia (Fredrickson Type Ⅱa), Dyslipidemia (Fredrickson Type Ⅱb) | Phase 1 | 2014-03-18 |
| Unknown | A Dose Selection Trial of CKD-330 in Patients With Essential Hypertension Essential Hypertension | Phase 2 | 2014-03-01 |
| Completed | A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function Liver Dysfunction | Phase 1 | 2014-03-01 |
| Completed | CKD-346 DDI Study(Telmisartan/S-Amlodipine, Rosuvastatin) Hypertension, Hyperlipidemia | Phase 1 | 2014-02-01 |
| Unknown | Efficacy and Safety of TELMINUVO to Stage 2 Hypertension Hypertension | Phase 3 | 2014-01-01 |
| Completed | Drug-drug Interaction Study(Lobeglitazone, Warfarin) Type 2 Diabetes Mellitus | Phase 1 | 2013-12-01 |
| Unknown | Efficacy and Safety of Fenofibrate Added on to Atorvastatin Compared With Atorvastatin Mixed Hyperlipidemia | Phase 3 | 2013-12-01 |
| Unknown | Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED) Rheumatoid Arthritis | Phase 2 | 2013-11-01 |
| Completed | Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg Immunosuppression | N/A | 2013-08-01 |
| Unknown | Study to Compare the Pharmacokinetic Characteristics and Safety of Dilatrend SR Capsule 32mg and Dilatrend Tab Essential Hypertension, Chronic Stable Angina, Congestive Heart Failure | Phase 1 | 2013-04-01 |
| Completed | Study to Investigate the Effect of Atorvastatin on the Pharmacokinetic Properties of Telmisartan/S-amlodipine Essential Hypertension, Hyperlipidemia | Phase 1 | 2013-04-01 |
| Completed | The Study to Evaluate Efficacy and Safety of Newrabell® Tab.(Rabeprazole Sodium) 10mg b.i.d in Refractory GERD Reflux Esophagitis | Phase 4 | 2013-04-01 |
| Completed | Study to Investigate the Effect of Telmisartan/S-amlodipine on the Pharmacokinetic Properties of Atorvastatin. Essential Hypertension, Hyperlipidemia | Phase 1 | 2013-04-01 |
| Completed | Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kid Kidney Transplantation | Phase 4 | 2013-01-01 |
| Completed | Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee Osteoarthritis of the Knee | Phase 4 | 2013-01-01 |
| Completed | Efficacy and Safety of Carvedilol SR Versus Carvedilol IR in Patients With Essential Hypertension Hypertension | Phase 3 | 2012-12-01 |
| Completed | The Study to Evaluate Efficacy and Safety of Imotun Capsule in Osteoarthritis of the Knee Osteoarthritis of the Knee | Phase 4 | 2012-12-01 |
| Completed | Pharmacokinetics Study of CKD-11101 and NESP After SC Administration in Health Male Volunteers Anemia | Phase 1 | 2012-10-26 |
| Completed | Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers Anemia | Phase 1 | 2012-10-12 |
| Completed | Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis Rheumatoid Arthritis | Phase 4 | 2012-08-01 |
| Completed | Efficacy and Safety of CKD-828 to Stage 2 Hypertension Hypertension | Phase 3 | 2012-07-01 |
| Completed | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2012-06-01 |
| Terminated | The Study to Evaluate Efficacy and Safety of Candesartan vs Losartan in Hypertension With Heart Failure (HONOR Hypertension | Phase 4 | 2012-06-01 |
| Completed | Safety and Pharmacokinetic Profile of CKD-581 Lymphoma, Multiple Myeloma | Phase 1 | 2012-05-01 |
| Completed | To Evaluate the Efficacy and Safety on Blood Pressure In Patients With Hypertension Diagnosed Congestive Heart Hypertension, Congestive Heart Failure | Phase 4 | 2012-01-01 |
| Completed | CKD-828 Telmisartan Non-Responder Trial Hypertension | Phase 3 | 2011-08-01 |
| Completed | CKD-828 S-Amlodipine Non-Responder Trial Hypertension | Phase 3 | 2011-08-01 |
| Completed | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combinati Coronary Artery Disease | Phase 1 | 2011-08-01 |
| Completed | A Randomized, Open-label, Single-dose, Crossover Clinical Trial to Evaluate the Food Effect on the Pharmacokin Chronic Stable Angina | Phase 1 | 2011-07-01 |
| Completed | CKD-828 Drug Interaction Study (Telmisartan) Healthy Male Volunteers | Phase 1 | 2011-06-01 |
| Completed | Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule Chronic Stable Angina | Phase 1 | 2011-06-01 |
| Completed | CKD-828 Drug Interaction Study (S-amlodipine) Healthy Male Volunteers | Phase 1 | 2011-05-01 |
| Completed | Drug-drug Interaction Study(CKD-501, Amlodipine) Type 2 Diabetes Mellitus | Phase 1 | 2011-04-01 |
| Completed | CKD-828(80/2.5mg) Pharmacokinetic Study_2nd Hypertension | Phase 1 | 2011-04-01 |
| Completed | Drug-drug Interaction Study (CKD-501, Ketoconazole) Type 2 Diabetes Mellitus | Phase 1 | 2011-03-01 |
| Completed | CKD-828 (40/5mg) Pharmacokinetic Study Hypertension | Phase 1 | 2011-01-01 |
| Completed | Belotecan Versus Topotecan for Recurrent Ovarian Cancer: A Randomized, Open-label, Parallel-group Phase IIb Tr Epithelial Ovarian Cancer | Phase 2 | 2011-01-01 |
| Completed | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combinati Coronary Artery Disease | Phase 1 | 2010-12-01 |
| Completed | Study to Evaluate the Pharmacokinetic Characteristics of Luckyvec 400mg Tablet, in Healthy Subjects Chronic Myeloid Leukemia, Gastrointestinal Stromal Tumors | Phase 1 | 2010-11-01 |
| Completed | CKD-828(80/2.5mg) Pharmacokinetic Study Hypertension | Phase 1 | 2010-11-01 |
| Completed | A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive- Small Cell Lung Cancer | Phase 2 | 2010-09-01 |
| Completed | CKD-828 Primary Hypertension Trial(Dose-selection) Hypertension | Phase 2 | 2010-07-01 |
| Completed | Efficacy and Safety of CKD-501 Versus Pioglitazone When Added to Metformin Type 2 Diabetes Mellitus | Phase 3 | 2010-05-01 |
| Completed | The Pharmacokinetic Interaction Between CKD-501 and Sulfonylurea Healthy Male Volunteer | Phase 1 | 2010-05-01 |
| Completed | The Effect of Food on the Pharmacokinetic Characteristics of CKD-501 Healthy | Phase 1 | 2010-03-01 |
| Completed | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | 2009-12-01 |
| Unknown | The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYL Evidence of Liver Transplantation | Phase 4 | 2009-11-01 |
| Completed | Drug Interaction Between CKD-501 and Metformin Healthy Male Volunteers | Phase 1 | 2009-10-01 |
| Completed | An Evaluation of Glycemic Control Effects of Mono Therapy CKD-501 in Patients With Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 3 | 2009-10-01 |
| Completed | Study of Camtobell Inj (Belotecan) on Weekly Schedule in Non-small Cell Lung Cancer (NSCLC) Patients Previousl Carcinoma, Non-Small-Cell Lung | Phase 2 | 2009-09-01 |
| Completed | Pharmacokinetic Study of CKD-810 and Taxotere to Treat Patient With Advanced Solid Cancer Advanced Solid Cancers | Phase 1 | 2009-08-01 |
| Completed | Study to Evaluate the Pharmacokinetic Characteristics of CKD-4101 (Mycophenolate Mofetil) Tablet Healthy | Phase 1 | 2009-07-01 |
| Completed | Dyslipidemia in Cardiovascular Disease Dyslipidemia | Phase 4 | 2008-08-01 |
| Completed | Evaluate the Glycemic Control of CKD-501 in Type 2 Diabetes Mellitus Diabetes Mellitus, Type 2 | Phase 2 | 2007-07-01 |